Finding & Developing Drugs for Rare Conditions
Host: Bruce Japsen Guest: Jeffrey Aronin, MBA It seems most drug-makers are making their biggest sales to doctors by pushing medicines for common conditions whether they be statins for cholesterol or proton pump inhibitors for heartburn. But drugs can actually take on blockbuster significance for specialized treatment groups where treatment options are limited. Jeffrey Aronin, president and CEO of Ovation Pharmaceuticals Inc. tells the Chicago Tribune's Bruce Japsen about his company's efforts to build blockbuster franchises by treating rare conditions.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Clinician's Roundtable?
This episode is 12 minutes long.
When was this Clinician's Roundtable episode published?
This episode was published on May 15, 2008.
Can I download this Clinician's Roundtable episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.